RxDoctor Payments Data

Richard Egelhof

Family Medicine · Wichita, KSNPI 1386647196

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,800 of the $2,219 with a category attached, or 81.1%. Eli Lilly accounts for 96.4% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $2,158, more than ten times the $25 reported in 2019.

$2,219in general payments, 2019–2025

Across 27 payments — averaging $82.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Novo Nordisk$28
  • Amgen$22
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$18
  • Takeda Pharmaceuticals U.S.A., Inc.$11
$4,084,938in research payments, 2019–2025

Across 1,394 payments — averaging $2930.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.4M
  • Emergent Biosolutions Inc.$896K
  • Johnson & Johnson$596K
  • Valneva Austria GmbH$384K
  • Vivus LLC$173K
  • Modernatx, Inc.$157K
  • plus $527K from 11 others

What the payments were for

  • Travel & lodging$1,80081%
  • Food & beverage$41919%

General payments by program year

19
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,219 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →